When the Endogenous Hallucinogenic Trace Amine N,N -Dimethyltryptamine Meets the Sigma-1 Receptor-Reference-Cited by-同舟云学术

When the Endogenous Hallucinogenic Trace Amine N,N -Dimethyltryptamine Meets the Sigma-1 Receptor

Published:2009-03-10 Issue:61 Volume:2 Page:
ISSN:1945-0877
Container-title:Science Signaling
language:en
Short-container-title:Sci. Signal.

Author:

Su Tsung-Ping¹,Hayashi Teruo¹,Vaupel D. Bruce²

Affiliation:

1. Cellular Pathobiology Section, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA.

2. Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 333 Cassell Drive, Baltimore, MD 21224, USA.

Abstract

An endogenous hallucinogenic compound binds to a ligand-gated chaperone.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference44 articles.

1. Following the trace of elusive amines

2. Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca

3. Identification ofN,N-dimethyltryptamine andβ-carbolines in psychotropic ayahuasca beverage

4. Dimethyltryptamine as a new psychotic agent.;Szara I.;Acta Physiol. Hung.,1957

5. Dimethyltryptamine: A new psychoactive drug.;Sai-Halasz A.;Psychiatr. Neurol. (Basel),1958

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psychoactive substances for the treatment of neuropsychiatric disorders;Asian Journal of Psychiatry;2024-11

2. “Immunohistochemical analysis of Sigma-1 receptor (σ-1R) expression in human pineal gland in relation to different causes of death”;Legal Medicine;2024-07

3. Deletion of Sigmar1 leads to increased arterial stiffness and altered mitochondrial respiration resulting in vascular dysfunction;Frontiers in Physiology;2024-04-29

4. The Potential Use of Dimethyltryptamine against Ischemia-reperfusion Injury of the Brain;Journal of Neuroscience and Neurological Disorders;2024-04-19

5. The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness;Psychoactives;2024-02-26